Related Experiment Videos
Transarterial balloon mitral valvuloplasty
U U Babic1, P Pejcic, Z Djurisic
1Cardiovascular Center Dragisa Misovic, Beograd, Yugoslavia.
Zeitschrift Fur Kardiologie
|January 1, 1987
Summary
Percutaneous transarterial balloon mitral valvuloplasty (PTBMV) effectively treated mitral stenosis, significantly increasing mitral valve area and reducing gradients. This minimally invasive procedure offers a valuable option for patients with moderate to severe mitral stenosis.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Mitral stenosis (MS) is a significant valvular heart disease.
- Percutaneous transarterial balloon mitral valvuloplasty (PTBMV) is a minimally invasive treatment option.
Purpose of the Study:
- To evaluate the efficacy and outcomes of PTBMV in patients with moderate to severe mitral stenosis.
Main Methods:
- 36 patients with moderate (27) and severe (9) MS underwent PTBMV between 1985 and 1986.
- Both single (25 mm) and double balloon techniques (15-20 mm) were employed.
- A transseptal sheath and guide wire technique facilitated the procedure.
Main Results:
- Mitral valve gradient decreased significantly (18 to 8.4 mm Hg, p<0.001).
- Mitral valve area (MVA) increased significantly (1.26 to 2.3 cm2, p<0.001, 87% increase).
- Type A MS showed greater MVA enlargement (127%) than Type B MS (53%).
Conclusions:
- PTBMV is an effective treatment for mitral stenosis, leading to significant improvements in mitral valve area and gradients.
- The double balloon technique may offer advantages in achieving greater valve area enlargement.
- While effective, PTBMV can result in mitral regurgitation in a small subset of patients.